| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Hong Ni | |
| Steven P Anderson | |||
| Gary A Boorman | |||
| K Gottschalk | |||
| Kevin T Morgan | |||
| Lynn M Crosby | |||
| Marilyn Easton | |||
| Roger H Brown | |||
| Warren M Casey | |||
| P2860 | cites work | Rapid analysis of gene expression (RAGE) facilitates universal expression profiling | Q39729689 |
| Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells | Q40736468 | ||
| SAGE transcript profiles for p53-dependent growth regulation | Q41092725 | ||
| Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes | Q46136481 | ||
| Gene expression analysis by transcript profiling coupled to a gene database query | Q46159559 | ||
| A novel method for real time quantitative RT-PCR. | Q46544663 | ||
| A strategy to identify differentially expressed genes using representational difference analysis and cDNA arrays | Q48386116 | ||
| High throughput analysis of differential gene expression | Q49968576 | ||
| Differential display of mRNA. | Q54126584 | ||
| Analysis of differential gene expression by display of 3' end restriction fragments of cDNAs | Q24567484 | ||
| Serial analysis of gene expression | Q27860777 | ||
| Functional discovery via a compendium of expression profiles | Q27938962 | ||
| Dissecting the regulatory circuitry of a eukaryotic genome | Q28131632 | ||
| Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction | Q28131789 | ||
| Normalization and subtraction: two approaches to facilitate gene discovery | Q28294574 | ||
| Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells | Q28572290 | ||
| Open systems: panoramic views of gene expression | Q29031506 | ||
| A genome-wide transcriptional analysis of the mitotic cell cycle | Q29547805 | ||
| Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries | Q29618999 | ||
| Gene expression profiles in normal and cancer cells | Q29619943 | ||
| New developments in the analysis of gene expression | Q33180878 | ||
| Computational methods for the identification of differential and coordinated gene expression. | Q33724059 | ||
| Genomic biology | Q33824748 | ||
| The principles and practice of toxigenomics: applications and opportunities | Q33896275 | ||
| Genomics, gene expression and DNA arrays | Q33906813 | ||
| Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations | Q33915649 | ||
| Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs | Q33939119 | ||
| Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology | Q34164559 | ||
| A biological atlas of functional maps | Q34175352 | ||
| Identifying differences in mRNA expression by representational difference analysis of cDNA | Q35004368 | ||
| Y-chromosomal SNPs in Finno-Ugric-speaking populations analyzed by minisequencing on microarrays | Q35033413 | ||
| TOGA: an automated parsing technology for analyzing expression of nearly all genes | Q35045426 | ||
| The existence of eukaryotic ribonucleoprotein consensus sequence-type RNA-binding proteins in a prokaryote, Synechococcus 6301. | Q36674173 | ||
| Normalization strategies for cDNA microarrays | Q39556546 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxicogenomics | Q841450 |
| drug discovery | Q1418791 | ||
| P304 | page(s) | 15-27 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Toxicologic Pathology | Q7830407 |
| P1476 | title | Toxicogenomics, drug discovery, and the pathologist | |
| P478 | volume | 30 |
| Q40104889 | Accelerating drug discovery. |
| Q30939430 | Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data |
| Q30939419 | Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics |
| Q35892040 | DNA-microarray analysis of brain cancer: molecular classification for therapy |
| Q37616455 | Environmental toxicogenomics: a post-genomic approach to analysing biological responses to environmental toxins. |
| Q24813069 | Modern classification of neoplasms: reconciling differences between morphologic and molecular approaches |
| Q28082201 | Pathological bases for a robust application of cancer molecular classification |
| Q28472125 | Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles |
| Q44765388 | Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system |
| Q39617511 | Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities |
| Q35603973 | Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings |
| Q36086424 | The hepatic transcriptome as a window on whole-body physiology and pathophysiology |
| Q37924048 | The role of the toxicologic pathologist in the biopharmaceutical industry |
| Q36962543 | The role of the toxicologic pathologist in the post-genomic era(#) |
| Q35614775 | Toxicogenomics in drug development |
| Q35973576 | Toxicoproteomics: proteomics applied to toxicology and pathology |
Search more.